Today: 20 February 2026
Subscribe
BAE Systems share price dips after fresh high as rally cools on profit-taking
·
20 February 2026
by

BAE Systems share price dips after fresh high as rally cools on profit-taking

BAE Systems shares fell 0.7% to 2,147 pence in early London trading after reaching a 52-week high, valuing the company at about £62.6 billion. The drop followed a 12% rise in full-year operating profit to £3.32 billion and a record order backlog. BAE forecast 7–9% higher sales and 9–11% higher operating profit in 2026. The company repurchased 30 million shares in 2025 for £502 million.
Read More
Compass Group stock inches up in London — here’s what matters before April’s dollar switch
·

Compass Group stock inches up in London — here’s what matters before April’s dollar switch

Compass Group shares rose 0.4% to 2,203 pence in early London trading Friday, extending gains after a sharp selloff earlier in February. Investors are watching an April 1 switch to U.S. dollar trading on the LSE and a Feb. 26 dividend payment. The stock remains sensitive to concerns over office demand and broader consumption shifts.
20 February 2026
by
Read More
RELX share price today: buyback filings keep the stock moving as April update nears

RELX share price today: buyback filings keep the stock moving as April update nears

RELX shares rose 1.1% to 2,319 pence by 0810 GMT after the company disclosed a 1.6 million-share buyback and published its annual report. The group has repurchased 17.28 million shares since January 2 and now holds 21.39 million in treasury. RELX flagged regulatory and cybersecurity risks in its filings. The buyback program runs through March 20 with a £450 million budget.
20 February 2026
··
Unilever share price in focus ahead of London open after India capex plan and broker downgrades

Unilever share price in focus ahead of London open after India capex plan and broker downgrades

Unilever shares closed at 5,320 pence in London, down 8 pence, after broker downgrades and news of a 20 billion rupee investment by Hindustan Unilever in premium manufacturing. Chief R&D Officer Richard Slater sold £1 million in shares. The company warned 2026 sales growth would hit the low end of guidance and announced a €1.5 billion buyback. Q1 results are due April 30.
20 February 2026
·
South32 share price slips to A$4.39 as copper volatility and dividend dates come into view

South32 share price slips to A$4.39 as copper volatility and dividend dates come into view

South32 shares closed down 0.45% at A$4.39 on Friday, with 13.2 million shares traded. The company plans to start care and maintenance at its Mozal aluminium smelter in Mozambique around March 15 after failing to secure affordable power. Its interim dividend goes ex-dividend on March 5. Markets are watching copper prices and the Feb. 24 reopening of Chinese trading after the Lunar New Year break.
20 February 2026
·
Ramsay Health Care share price jumps on Ramsay Santé spin-off plan — what investors watch next week

Ramsay Health Care share price jumps on Ramsay Santé spin-off plan — what investors watch next week

·
20 February 2026
Ramsay Health Care shares rose 3.0% to A$38.62 Friday after announcing plans to spin off its 52.79% stake in French-listed Ramsay Santé to shareholders via in-specie distribution. The split, targeted for late 2026, awaits board, court, and regulatory approvals. Investors now focus on the Feb. 26 interim results and further details on the separation process.
Read More
Paladin Energy share price jumps after Canada clears key step for Patterson Lake South uranium project

Paladin Energy share price jumps after Canada clears key step for Patterson Lake South uranium project

··
20 February 2026
Paladin Energy shares rose 3.3% to A$13.67 after securing Saskatchewan ministerial approval for the Environmental Impact Statement at its Patterson Lake South uranium project in Canada. The decision clears a key provincial hurdle, with federal licensing steps still ahead. Other uranium stocks also gained as spot prices held near $89 a pound. Paladin resumed trading after a brief halt pending the announcement.
Read More
Telix (ASX:TLX) share price jumps 14% on 2026 revenue outlook — what moved the stock

Telix (ASX:TLX) share price jumps 14% on 2026 revenue outlook — what moved the stock

··
20 February 2026
Telix Pharmaceuticals shares closed up 14.2% at A$10.43 in Sydney after reporting 2025 revenue rose 56% to US$803.8 million and forecasting 2026 revenue of US$950 million to US$970 million. The company filed for European approval of its TLX101-Px brain cancer imaging agent earlier in the week. Telix ended 2025 with US$141.9 million in cash and posted a US$5.3 million pre-tax loss.
Read More
Mineral Resources shares drop 5% after record half-year earnings — what ASX investors watch next

Mineral Resources shares drop 5% after record half-year earnings — what ASX investors watch next

···
20 February 2026
Mineral Resources shares fell 5.3% to A$51.25 after posting record first-half revenue of A$3.1 billion and net profit of A$573 million but skipping an interim dividend. The company cut net debt to A$4.9 billion and reaffirmed FY26 guidance, with focus now on debt reduction and the timing of a US$765 million POSCO lithium deal.
Read More
Whitehaven Coal share price falls again as buyback starts after half-year loss

Whitehaven Coal share price falls again as buyback starts after half-year loss

··
20 February 2026
Whitehaven Coal shares dropped 2.7% to A$7.81 on Friday after posting a first-half underlying net loss of A$19 million and announcing a small buyback. Revenue for the half fell to A$2.5 billion as coal prices softened. Net debt stood at A$710 million, with a US$500 million deferred acquisition payment due in April. The company declared a 4-cent interim dividend, payable March 13.
Read More
Evolution Mining share price edges up despite chair’s 3.25 million-share sell-down; gold and dividend date in focus

Evolution Mining share price edges up despite chair’s 3.25 million-share sell-down; gold and dividend date in focus

····
20 February 2026
Evolution Mining shares closed up 0.7% at A$15.05 in Sydney after chair Jacob Klein disclosed selling 3.25 million shares at an average A$15.76 each. Klein retains 7.75 million shares and 1.56 million performance rights. Gold hovered near $5,000 an ounce but was set for a weekly drop as the dollar strengthened ahead of U.S. inflation data.
Read More
Ethereum near $1,950 as NFT “utility” pitch meets Polymarket’s $1.17 million price bet

Ethereum near $1,950 as NFT “utility” pitch meets Polymarket’s $1.17 million price bet

··
20 February 2026
Ether traded at $1,955.79 on Friday, down 0.73% in 24 hours, with $18 billion in volume, CoinMarketCap reported. Polymarket users wagered $1.17 million on ether price contracts, with settlements above $1,500 and $1,900 but not $2,000. Ethereum co-founder Vitalik Buterin warned prediction markets risk becoming “low-value gambling.” Bitcoin hovered near $67,088 late Thursday, according to Dow Jones data.
Read More
Fortescue stock price slips to A$20 — what’s next for FMG ahead of earnings and Wyloo North

Fortescue stock price slips to A$20 — what’s next for FMG ahead of earnings and Wyloo North

···
20 February 2026
Fortescue Ltd shares closed down 1.3% at A$20.04 on Friday, with 6.4 million shares traded. The company’s Wyloo North iron ore mine proposal, targeting 12 million tonnes a year, faces public comment until Feb. 24. Benchmark 62% Fe iron ore futures last traded at $99.61 a tonne. Fortescue’s half-year results are due Feb. 25.
Read More
Wesfarmers shares wobble after profit beat, as dividend date and consumer demand come into view

Wesfarmers shares wobble after profit beat, as dividend date and consumer demand come into view

···
20 February 2026
Wesfarmers shares fell 0.3% to A$83.99 on Friday, extending a 5.6% drop after its results. The company reported first-half net profit of A$1.6 billion, up 9.3%, and raised its interim dividend to A$1.02 a share. Shares go ex-dividend Feb. 24, with payment due March 31. CEO Rob Scott warned of uneven consumer spending and flagged price cuts funded by productivity and AI.
Read More
Zip Co (ASX:ZIP) share price: A$50m buyback plan lands after brutal earnings slump

Zip Co (ASX:ZIP) share price: A$50m buyback plan lands after brutal earnings slump

···
20 February 2026
Zip shares closed at A$1.78 Friday, down 3.8% after a 34% drop Thursday. The company announced an up to A$50 million on-market buyback starting around March 6. Investors reacted to flat second-half earnings guidance despite upgraded margin targets and rising credit losses. Cash EBITDA for the half-year rose 86% to A$124.3 million, but results missed expectations.
Read More
Woodside Energy stock rises as oil stays near 6‑month highs — what to watch next week

Woodside Energy stock rises as oil stays near 6‑month highs — what to watch next week

···
20 February 2026
Woodside Energy shares rose 1.2% to A$27.43 on Friday as oil prices hit six-month highs amid U.S.-Iran tensions. The S&P/ASX200 slipped 0.05%, while Santos dropped 0.9% after a new gas deal with South Australia. Woodside will release its 2025 annual report and full-year update next Tuesday. Traders remain focused on oil prices and upcoming company guidance.
Read More
Telstra share price today: TLS slips after buyback boost as dividend dates loom

Telstra share price today: TLS slips after buyback boost as dividend dates loom

···
20 February 2026
Telstra shares closed at A$5.11, down 0.6% Friday, after surging to a multi-month high on Thursday’s half-year results. The company raised its on-market buyback to A$1.25 billion and narrowed FY26 EBITDAaL guidance to A$8.2–8.4 billion. Telstra declared a 10.5 cent interim dividend, with the stock going ex-dividend Feb. 25. Profit for the half rose 9.4% to A$1.124 billion.
Read More
CSL share price slips as buyback tally grows; Lilly deal sets up next week

CSL share price slips as buyback tally grows; Lilly deal sets up next week

····
20 February 2026
CSL shares fell 0.6% to A$153.27 Friday, ending a two-day rebound. The company disclosed a 69,497-share buyback for A$10.7 million and confirmed a new licensing deal with Eli Lilly for clazakizumab, including a $100 million upfront payment. Director Alison Watkins acquired 214 shares under a board plan. Investors are watching buyback pace and updates on the Lilly agreement next week.
Read More
Go toTop